Why Are Participants in Novavax's COVID Vaccine Study Receiving 2 Extra Shots?

Like most of the other COVID-19 vaccines that have already won Emergency Use Authorization (EUA), Novavax's (NASDAQ: NVAX) vaccine requires two shots spread several weeks apart. But the biotech recently announced that participants in its late-stage clinical studies will have the option to receive two additional shots. In this Motley Fool Live video recorded on April 7, Motley Fool contributors Keith Speights and Brian Orelli talk about why Novavax is making this move.

Continue reading

Source Fool.com